Your browser doesn't support javascript.
loading
Centbutindole vs trifluoperazine: a double-blind controlled clinical study in acute schizophrenia.
J Postgrad Med ; 1989 Jan; 35(1): 3-8
Article ي En | IMSEAR | ID: sea-117542
Twenty-nine acute schizophrenic patients were treated under double-blind conditions for six weeks with either centbutindole in a dose range of 3 mg/day to 4.5 mg/day or trifluoperazine in the dose range of 15 mg/day to 22.5 mg/day. Both drugs produced a significant improvement in initial psychopathology. No significant differences were demonstrated between the two treatment conditions.
الموضوعات
النص الكامل: 1 الفهرس: IMSEAR الموضوع الرئيسي: Pyrazines / Schizophrenia / Trifluoperazine / Female / Humans / Male / Random Allocation / Double-Blind Method / Clinical Trials as Topic / Adult نوع الدراسة: Clinical_trials اللغة: En مجلة: J. postgrad. med السنة: 1989 نوع: Article
النص الكامل: 1 الفهرس: IMSEAR الموضوع الرئيسي: Pyrazines / Schizophrenia / Trifluoperazine / Female / Humans / Male / Random Allocation / Double-Blind Method / Clinical Trials as Topic / Adult نوع الدراسة: Clinical_trials اللغة: En مجلة: J. postgrad. med السنة: 1989 نوع: Article